Concepedia

Liang Cao

LC

Statistics

Publications

158

Citations

9.4K

H-Index

48

Active since

1990

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

Kanion Pharmaceutical (China)

National Institutes of Health

University of Hong Kong

Liang Cao is an author at National Cancer Institute specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

1990–2024

158

Publications

158

A pathway for generation and processing of double-strand breaks during meiotic recombination in S. cerevisiae

Liang Cao, Eric Alani, Nancy Kleckner · Cell · 1990 · 686 citations

, , +16

Temporal comparison of recombination and synaptonemal complex formation during meiosis in S. cerevisiae

Ruth Padmore, Liang Cao, Nancy Kleckner · Cell · 1991 · 455 citations

, , +16

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

Julius Strauss, Christopher R. Heery, Jeffrey Schlom et al. · Clinical Cancer Research · 2018 · 415 citations · Full text

, , +17

Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F

Liang Cao, Barbara Faha, Marlene Dembski et al. · Nature · 1992 · 374 citations

, , +16

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

Nilofer S. Azad, Edwin M. Posadas, Virginia E. Kwitkowski et al. · Journal of Clinical Oncology · 2008 · 337 citations · Full text

, , +15

1–5 of 158